Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Rocket Pharmaceuticals Inc shares valued at $15,978 were sold by Militello John on Nov 21 ’24. At $13.05 per share, Militello John sold 1,224 shares. The insider’s holdings dropped to 49,310 shares worth approximately $0.52 million following the completion of this transaction.
Also, Patel Kinnari sold 4,588 shares, netting a total of over 59,892 in proceeds. Following the sale of shares at $13.05 each, the insider now holds 392,395 shares.
Before that, Shah Gaurav had sold 11,091 shares from its account. In a trade valued at $144,782, the CEO traded Rocket Pharmaceuticals Inc shares for $13.05 each. Upon closing the transaction, the insider’s holdings decreased to 11,091 shares, worth approximately $7.41 million.
As published in their initiating research note from Wedbush on December 30, 2024, Rocket Pharmaceuticals Inc [RCKT] has been an Outperform and the price target has been revised to $32. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in mid December. As of October 16, 2024, Scotiabank has initiated its “Sector outperform” rating for RCKT. Earlier on April 02, 2024, Goldman initiated its rating. Their recommendation was “a Neutral” for RCKT stock.
Analyzing RCKT Stock Performance
During the last five days, there has been a surge of approximately 0.48%. Over the course of the year, Rocket Pharmaceuticals Inc shares have dropped approximately -16.63%. Shares of the company reached a 52-week high of $13.35 on 01/02/25 and a 52-week low of $10.07 on 01/22/25. A 50-day SMA is recorded $12.91, while a 200-day SMA reached $18.82. Nevertheless, trading volume fell to 1.5 million shares from 1.44 million shares the previous day.
Support And Resistance Levels for Rocket Pharmaceuticals Inc (RCKT)
According to the 24-hour chart, there is a support level at 10.17, which, if violated, would cause prices to drop to 9.85. In the upper region, resistance lies at 10.70. The next price resistance is at 10.91. RSI (Relative Strength Index) is 35.84 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.03, which suggests the price will decrease in the coming days. Percent R is at 87.50%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
